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Summary 
About this report 
This is the first report of a projected series regarding the comorbidity of cardiovascular 
disease (CVD), diabetes and chronic kidney disease (CKD) in Australia. Comorbidity refers 
to any two or more of these diseases that occur in one person at the same time. The questions 
to be answered in this report include: 
1. How many Australians have comorbidity of CVD, diabetes and CKD? 
2. What is the proportion of hospitalisations with these comorbidities? 
3. How much do these comorbidities contribute to deaths? 
4. What is the magnitude of comorbidity in the context of each individual disease? 
5. Are there differences in the distribution of these comorbidities among age groups and 
sexes? 
Key findings 
1. In 2004–05, 417,563 (2.9%) adults not living in institutions had comorbidity of CVD and 
diabetes. In 2003, 14,722 (8.1%) people in institutions, such as nursing homes and aged 
care hostels, had this comorbidity.  
2. Comorbidities of CVD, diabetes and CKD were found in 365,245 (6.6%) non-dialysis 
hospital separations for adults in 2004–05.  
3. Comorbidities of CVD, diabetes and CKD were recorded as causes of death for  
17,239 (13.2%) people who died in 2004.  
4. The observed rates of these comorbidities exceeded the rates expected if conditions only 
occurred together by chance.  
5. CVD was very common among people with diabetes and CKD. In turn, both diabetes and 
CKD contribute to many cases of CVD. 
6. Older people were more likely to have these comorbidities than younger people. Males 
were more likely to have these comorbidities than females. 
Messages 
1. Comorbidity of CVD, diabetes and CKD is mainly caused by complex interrelationships 
between these conditions and shared risk factors. There is potential to reduce the 
associated burden by controlling common risk factors and improving disease 
management. 
2. These comorbidities mainly affect older people. With a rapidly ageing population, 
comorbidity will rise. Australian health systems need to be prepared to meet an 
increasing demand on health services from people with comorbidities.
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1 Introduction 
Cardiovascular disease (CVD), diabetes and chronic kidney disease (CKD) are serious 
illnesses that contribute significantly to deaths and levels of ill health in the Australian 
population. CVD, diabetes and CKD share many risk factors, such as obesity and old age. 
There are also complex causal relationships between these diseases, and each of them may be 
caused by, or be a complication of, one or both of the other diseases. As a result, they are 
more likely to occur together—this is known as comorbidity. The presence of comorbidity is 
often regarded as an indicator of severity and poorer prognosis of these diseases. The clinical 
management for people with comorbidity is much more complex and time consuming than 
for those with single diseases. 
Because of the ageing Australian population and the high prevalence of CVD, diabetes and 
CKD, comorbidity of these diseases is expected to rise. Although comorbidity of these 
diseases is receiving increased attention, most studies focus on one disease at a time and 
there are relatively few studies that include investigations of the relationship of multiple 
chronic diseases (Walker 2005). The extent of comorbidity in Australia and its impact on 
people’s health and on the health system are not clear. The National Centre for Monitoring 
Cardiovascular Disease and the National Centre for Monitoring Diabetes have therefore 
collaborated to investigate the association of these diseases and their impact on the 
Australian population.  
What are cardiovascular disease, diabetes and 
chronic kidney disease? 
Cardiovascular disease 
CVD is any disease of the heart (cardio) or blood vessels (vascular). Some forms of CVD are 
very common in Australia, including hypertension (high blood pressure), coronary heart 
disease (CHD), heart failure and cerebrovascular disease.  
CVD is one of the leading causes of disability and death in Australia. Combining both the 
burden from premature deaths and extent of associated disability, cardiovascular disease 
was estimated to account for 17% of the overall disease burden in Australia in 2003 (AIHW 
2006a). CVD is the most expensive disease group in terms of direct health care expenditure, 
at over $5.5 billion, which represents 11% of Australia’s total allocated health system 
expenditure in 2000–01 (AIHW 2004a).  
Diabetes 
Diabetes mellitus (in this report referred to as diabetes) is a chronic condition in which blood 
glucose levels become too high as a result of the body producing insufficient insulin, or 
being unable to use insulin properly. Diabetes can lead to a range of complications, including 
coronary heart disease and stroke, as well as kidney disease and retinopathy (loss of vision). 
Self-reported data in the 2004–05 National Health Survey (NHS) showed that about  
699,600 Australians (3.5% of the population) had been diagnosed with diabetes  
  2
(AIHW 2006a). Diabetes accounted for 5.8% of the overall disease burden in Australia in 
2003 (AIHW 2006a). In 2004, 11,735 deaths in Australia were associated with diabetes  
(AIHW 2006a).  
Chronic kidney disease 
CKD is the occurrence of kidney damage and/or reduced kidney function, lasting for at least 
three months. It is classified into five stages from stage 1 (least severe) to stage 5 (most 
severe) where patients may need to undergo kidney replacement therapy (dialysis or 
transplant), as kidney function is not sufficient to sustain life (AIHW 2005).  
How many Australians are affected by CKD is unknown. Some investigators have suggested 
that about 7.5% to 11.2% of Australian adults have signs of kidney damage or reduced 
kidney function (Chadban et al. 2003, The Australasian Creatinine Consensus Working 
Group 2005). CKD imposes a substantial burden of disease in Australia. In 2004, CKD was 
recorded as the underlying cause of death in 2,361 cases (2% of all deaths). CKD was an 
associated cause of death in 9,609 cases—43% of these were recorded with cardiovascular 
disease as the underlying cause of death and 9% with diabetes (AIHW 2006a). For an 
explanation of underlying and associated causes of death see page 30. 
What is comorbidity and how does it happen? 
What is comorbidity? 
Comorbidity refers to any two or more diseases that occur in one person at the same time. In 
this report comorbidity refers to the presence of CVD, diabetes or CKD in combination with 
one or both of the other diseases.  
Causes of comorbidity 
Co-occurrence of diseases can happen by chance. Some diseases can coexist in one person by 
coincidence, and there is no pathological association between them. However, more often 
than not, diseases occur together because there are some associations between them. These 
associations can be summarised into two main groups: direct and indirect causal 
relationships between the diseases and shared risk factors. The direct and indirect causal 
relationships between CVD, diabetes and CKD have been demonstrated by substantial 
evidence from pathological and epidemiological studies.  
Diabetes is a well known risk factor for CVD. The reasons why diabetes increases the risk of 
CVD are only partially understood. One established explanation is that diabetes increases 
atherosclerosis (thickening of the wall of a blood vessel with deposits of plaque), which is the 
underlying cause of most CVD in Australia. It is also established that people with diabetes 
tend to have higher levels of blood pressure and abnormal cholesterol level, both of which 
are factors that increase the risk of atherosclerosis and CVDs (AIHW 2002a).  
Diabetes can also lead to kidney damage—a complication known as diabetic nephropathy. 
Diabetic nephropathy results from high blood glucose levels damaging the blood-filtering 
capillaries in the kidneys. Moreover, diabetes also increases the risk of kidney damage and 
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accelerates the reduction of kidney function by increasing the risk of hypertension  
(AIHW 2005).  
CKD has been found to independently increase the risk of hypertension and other 
cardiovascular diseases, including heart attack, angina, coronary artery disease, stroke and 
heart failure. The risks of a cardiovascular event, such as heart attack or stroke, are greater in 
those with poorer kidney function (Go et al. 2004). The reasons for excess risk of CVD among 
people with CKD are not clearly understood. However, some established risk factors of 
CVD, such as obesity, abnormal lipid levels and diabetes, are also common among people 
with CKD. In addition, CKD complications, such as anemia and disturbed mineral 
metabolism, also contribute to increased risk of CVD (Levin et al. 2002).  
CVD, especially hypertension, is one of the major causes of CKD. Untreated high blood 
pressure can damage the blood vessels in the kidneys. The walls of these blood vessels 
become thick and the internal diameter narrowed, leading to reduced blood supply and 
decreased kidney function. Among people with CKD, the presence of CVD is associated with 
a faster decline of kidney function and the need for dialysis (Levin et al. 2001). 
Furthermore, shared risk factors of these diseases also promote co-occurrence of these 
diseases and strengthen the association between them. These risk factors do not just affect 
the onset of CVD, diabetes and CKD, but also affect their progression and increase the risk of 
complications. These risk factors include ageing, gender, overweight or obesity, lifestyle and 
socioeconomic conditions (Table 1.1). Other factors, such as genetic background and 
environmental factors, also play some role in the co-occurrence of these diseases.  
Because of these complex interactions, the risk of developing these diseases and their 
comorbidities is even greater among those with multiple risk factors. This is especially true 
for people with metabolic syndrome. Metabolic syndrome is a cluster of risk factors 
comprising excess abdominal weight, insulin resistance, hypertension (high blood pressure) 
and/or lipid abnormalities. The risk of having CVD, diabetes and CKD among people with 
metabolic syndrome is three times as high as for those without (Dekker et al. 2005; Stern et 
al. 2004). People with Type 2 diabetes who also have this syndrome are more likely to 
develop CVD complications and have kidney problems (Isomaa et al. 2001). 
Table 1.1: Known risk factors for cardiovascular disease, diabetes and chronic kidney disease  
Diseases Non-modifiable risk factors Modifiable risk factors 
Diabetes Age, genetic factors, pregnancy,  
low birth weight 
Overweight and obesity, poor nutrition, impaired glucose 
tolerance, physical inactivity.  
Cardiovascular disease Age, genetic factors, male sex, family 
history 
Overweight and obesity, poor nutrition, impaired glucose 
tolerance, physical inactivity, smoking, high blood 
pressure, diabetes, chronic kidney disease, atrial 
fibrillation, heavy alcohol consumption. 
Chronic kidney disease Age, genetic factors, family history, 
ethnicity 
Overweight and obesity, poor nutrition, impaired glucose 
tolerance, physical inactivity, smoking, high blood 
pressure, diabetes, urinary tract infections, kidney and 
urinary stones, glomerulonephritis, streptococcal 
infections, drug toxicity. 
Sources: AIHW 2002a, 2004b, 2005. 
Ageing is another factor that has a particularly strong association with many forms of 
comorbidity, including comorbidity of CVD, diabetes and CKD. Although such an 
association is widely accepted as ‘common wisdom’, the causes of the association have not 
been well studied. However, there are several possible explanations. Firstly, there is 
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concordance between the natural course of these diseases and people’s age. All of these 
diseases are more likely to first arise among middle aged to old people. Complications of 
these diseases may develop over a considerable period (about 10–20 years) after the onset of 
the original disease. By the time comorbidity presents, most of these people are at an old or 
very old age. The period between onset of the disease and its comorbidity is extremely 
important for the prevention and management of comorbidity, as early detection and better 
management of the original disease can effectively reduce the risk of comorbidity and/or 
delay its occurrence. Secondly, increased life expectancy in recent years in Australia is 
largely attributed to a reduction in death rates among older Australians, especially from 
diseases such as coronary heart disease and stroke (AIHW 2002b). Longer survival with 
chronic conditions allows the complications of these conditions to develop. Thirdly, the 
functions of organs gradually decline with age after middle age. Thus, older people are 
usually more vulnerable to the onset of diseases and their complications than younger 
people. 
Consequences of comorbidity  
The presence of these comorbidities in patients with CVD, diabetes and CKD often indicates 
more severe disease and poorer prognosis. These comorbidities have strong negative effects 
on health status and health services. Although the exact extent of the negative effects has not 
been well studied, it is widely recognised that such effects may go beyond the bare sum of 
the effects of each single disease. 
An excess risk of being hospitalised or dying has been documented in people with some 
combinations of these diseases, compared with people with only one of these diseases. It was 
found that CVD mortality among people without a previous heart attack was 7.5 times 
higher among those with Type 2 diabetes than in those without diabetes (Haffner et al. 1998). 
People with comorbidity of CVD and CKD were 35% more likely to have recurrent 
cardiovascular events or die than people with CVD alone (Weiner et al. 2004). People with 
comorbidity also have an increased risk of impaired functional status or quality of life 
(Gijsen et al. 2001). Apart from the individual human suffering, comorbidity also increases 
the burden on health care services. Comorbidity is associated with greater health care 
utilisation, including more hospital admissions, longer stays in hospital (Gijsen et al. 2001), 
and greater frequency of visits to GPs and specialists (Starfield et al. 2003, Struijs et al. 2006).  
Furthermore, clinical treatment for people with comorbidity is much more complex and time 
consuming than for those with a single condition. Health care for people with comorbidity 
needs to focus on a number of conditions at the same time. Multiple medications and 
therapies are required in almost all cases. The risk of dangerous interactions of multiple 
drugs is increased. People with comorbidity are also more likely to have complications after 
receiving common procedures, including some lifesaving procedures. Because of this, 
doctors may be reluctant to arrange such procedures for them (Levin et al. 2002).  
Higher health care usage and complex treatments have led to higher health care costs. A 
study conducted in Canada estimated that about 26.4% of health expenditure for diabetes 
was attributed to CVD-related services and 7.5% was attributed to kidney-related services. It 
also found that as the number of major complications increased, expenditure grew 
significantly (Simpson et al. 2003).  
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Implications for disease prevention, management 
and health policy 
Although comorbidity increases the health burden for individuals and society, there is 
substantial evidence that a large improvement in health can be achieved by prevention, early 
recognition and adequate treatment of comorbid diseases (Gijsen et al. 2001, Nilsson & 
Berglund 2000).  
Better understanding and regular monitoring of comorbidity of these diseases are critical to 
recognising the health burden of these diseases, developing strategies and formulating 
health care policy, and evaluating progress in disease prevention and management. 
Purpose, scope and structure of this report 
This report is designed to examine the current extent of comorbidity of these diseases among 
Australian adults from three perspectives: prevalence, hospitalisation and mortality. It 
focuses on analysing the distribution of comorbidity by age and sex. The actual occurrence of 
comorbidity is compared with the statistically expected occurrence to determine if these 
diseases coexist by chance. The distribution of comorbidity is also presented separately in the 
context of each individual disease. Further and more detailed investigations of other 
characteristics of these comorbidities, such as the differences between the Indigenous and 
non-Indigenous populations, are planned for future reports in this series. 
Although CVD, diabetes and CKD can occur among people at any age, they are mainly 
prevalent among the adult population, especially older people. Comorbidities from these 
diseases are rarely seen before the age of 18 years. Therefore, the analyses presented in this 
report focus on Australians aged 18 years or over.  
Besides this introduction, the main body of the report consists of the following chapters:  
• Chapter 2 focuses on the prevalence of comorbidity of CVD and diabetes in the 
Australian population. It includes analysis of data from the ABS 2004–2005 National 
Health Survey (NHS) and 2003 Survey of Disability, Ageing and Carers (SDAC).  
• Chapter 3 investigates the proportion of hospitalisations with comorbidity of CVD, 
diabetes and CKD in 2004–05.  
• Chapter 4 presents analysis of deaths associated with comorbidity of CVD, diabetes and 
CKD based on data from the AIHW National Mortality Database for 2004. 
• The main findings and implications are discussed in Chapter 5.  
The appendixes contain details of the methods, disease classifications, and data sources used 
in this report. 
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2 Prevalence  
To examine the extent of the problem of comorbidity in the population, the most critical 
questions to be answered are:  
• how many people have two conditions?  
• what is their distribution among age groups and sexes? 
This chapter focuses on these questions.  
The results shown in this chapter were drawn from the 2004–05 NHS and the 2003 SDAC. 
Both surveys were conducted by the Australian Bureau of Statistics (ABS). 
The NHS was designed to obtain national information on the health status of Australians, 
their use of health services and facilities, and health-related aspects of their lifestyle. The 
most recent NHS was conducted in 2004–05, and it included 25,906 people of all ages across 
urban and rural areas of Australia. Questions regarding long-term health conditions, 
including cardiovascular conditions and diabetes, were asked of the respondents at 
interview. Because it focussed on the non-institutionalised population, non-private 
dwellings (such as hospitals, nursing homes, hotels and boarding houses) were excluded 
(ABS 2006b). 
In the SDAC, national information was collected on the disability levels of Australians, their 
current and future care needs and the role of carers. The most recent SDAC was conducted 
in 2003, with 41,233 Australians participating. The survey included people in both private 
and non-private dwellings, such as hotels, motels, boarding houses, retirement villages, 
hospitals and nursing homes (ABS 2005). All survey participants were asked questions 
regarding their long-term health conditions. However, because the survey was designed to 
obtain information related to disability, participants were more likely to report long-term 
conditions related to their disability, rather than all long-term conditions. Nevertheless, it is a 
unique source of health information regarding long-term conditions among the 
institutionalised population.  
Because both were self-reported surveys, the results were influenced by the questionnaires 
used, and knowledge and awareness of specific conditions in the population. There is 
evidence that self-reported surveys are likely to underestimate the prevalence of diabetes, as 
some people were not aware that they had diabetes (Dunstan et al. 2001), and therefore 
would not report the condition.  
The prevalence of CKD is not available from either survey. Thus the analysis here is limited 
to comorbidity of CVD and diabetes. 
Due to constraints of the data sources, the analysis was restricted to people aged 20 years 
and older. The sub-categories of CVD were not consistent between the non-institutionalised 
and institutionalised populations for the same reason (Table A2 and A3).  
7Comorbidity of CVD and diabetes in the
non-institutionalised population
Based on the 2004–05 NHS, it was estimated that 3,452,510 (23.9%) of the non-
institutionalised population aged 20 years and over had CVD, 689,051 (4.8%) had diabetes, 
and 417,563 (2.9%) had both CVD and diabetes (Figure 2.1). In total, 25.8% of this population 
had at least one of these conditions. 
Note: People aged 20 years and over only are included.  
Source: AIHW analysis of 2004–05 ABS National Health Survey Confidentialised Unit Record File. 
Figure 2.1: Prevalence of CVD and diabetes and their comorbidity in the non-institutionalised 
adult population, 2004–05  
Age
There was a strong association between age and the presence of comorbidity of CVD and 
diabetes. The age-specific prevalence rate increased sharply with age from less than 1% in 
the 20–44 years age group to 10.2% in the 65–74 years age group, and then decreased slightly 
to about 9.0% in those aged 85 years and over (Figure 2.2—detailed data can be found in  
Table A4). After adjusting for sex, older people (aged 65 years and over) were 7.2 times as 
likely as younger people (under 65 years) to have both diseases (Table 2.1). 
Sex
It was estimated that 213,150 (3.0%) men and 204,414 (2.8%) women had both CVD and 
diabetes in 2004–05. While the prevalence rate was nearly the same for men and women 
before the age of 65 years, it was much higher among men than women aged 65–84 years 
(11.4% versus 8.0%, respectively). However, the rates were reversed between men and 
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women after they reached 85 years (7.8% versus 9.9%) (Figure 2.2). After adjusting for age, 
men were 1.2 times as likely as women to have both diseases (Table 2.1). 
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Note: People aged 20 years and over only are included. Due to small sample size, those aged 20–44 years were grouped for analysis. 
Source: AIHW analysis of 2004–05 ABS National Health Survey Confidentialised Unit Record File.  
Figure 2.2: Age-specific rate of comorbidity of CVD and diabetes in the non-institutionalised 
adult population, by sex, 2004–05 
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Table 2.1: Prevalence of comorbidity of CVD and diabetes in the non-institutionalised adult 
population, by sex and age group, 2004–05  
Comorbidty Men Women 
Odds ratio 
men to women
(95% CI)  
Under 65 
years 
65 years 
and over 
Odds ratio
65 years and over 
to under 65 years
 (95% CI) 
CVD and diabetes 213,150 
(3.0%) 
204,414 
(2.8%) 
1.16  
(1.15–1.16)  
178,690 
(1.5%) 
238,871 
(9.8%) 
7.22   
(7.18–7.27) 
Total estimated 
non-institutionalised 
population 7,099,402 7,333,436 —  11,992,786 2,440,052   — 
CI Confidence interval 
Notes 
1. Odds ratio is calculated using logistic regression model, and all p values are less than 0.001 See Appendix for explanation of logistic 
regression. 
2. People aged 20 years and over only are included.  
Source: AIHW analysis of ABS 2004–05 National Health Survey Confidentialised Unit Record File 
Observed and expected comorbidity in the non-institutionalised 
adult population 
CVD and diabetes may occur together by chance. The expected comorbidity prevalence rate 
is the rate that we would expect if the comorbidity arose purely from chance. The ratio of the 
observed to the expected rate is a measure of how much more comorbidity has occurred in 
the population than would have been expected purely by chance (see Appendix for a full 
discussion of the expected and observed rates).  
In 2004–05, the actual prevalence rate of comorbidity of CVD and diabetes observed in the 
Australian non-institutionalised population was 2.6 times as high as the rate expected  
(Table 2.2). This suggests that the high prevalence of comorbidity of CVD and diabetes is 
attributable to a strong association between two conditions. Because of this association, the 
existence of one disease causes or promotes the onset of the other disease. If all the factors 
that lead to this association, such as shared risk factors and a causal relationship, could be 
prevented, the prevalence of this comorbidity in this population could potentially be greatly 
reduced.   
Table 2.2: Expected and observed prevalence of comorbidity of CVD and diabetes in the  
non-institutionalised adult population, 2004–05 
Comorbidity 
Expected 
prevalence rate 
Observed 
prevalence rate 
Ratio observed to expected
(95% CI) 
CVD and diabetes  1.1% 2.9% 2.64 (2.37–2.89) 
CI Confidence interval 
Notes 
1. People aged 20 years and over only are included.  
2. Expected rate based on 23.9% with CVD and 4.8% with diabetes (23.9% × 4.8% = 1.1%). 
Source: AIHW analysis of ABS 2004–05 National Health Survey Confidentialised Unit Record File. 
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Comorbidity among people with CVD 
On average, almost 1 in 8 people (12.1%) with CVD also had diabetes. It was estimated that 
about 21.8% of people with CHD had diabetes, followed by heart failure (21.6%), 
cerebrovascular disease (17.4%, mainly stroke) and hypertensive disease (15.2%) (Table 2.3).  
Among people who reported CVD, those with diabetes increased from less than 2.9% in the 
20–44 years group to over 19.4% in the 65–74 years group, and then declined to about 14.0% 
in the 85 years and over group (Figure 2.3).  
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Note: People aged 20 years and over only are included. Due to the small sample size, people aged 20–44 years were grouped for analysis. 
Source: AIHW analysis of 2004–05 ABS National Health Survey Confidentialised Unit Record File.  
Figure 2.3: Comorbidity of CVD and diabetes among people with CVD in the  
non-institutionalised adult population, by age group, 2004–05 
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Comorbidity among people with diabetes 
According to the 2004–05 NHS, more than 60% of people with diabetes had at least one form 
of CVD. It was estimated that about 46.1% of them had hypertensive disease, 10.6% had 
CHD, 8.2% had heart failure and 2.3% had cerebrovascular disease. The prevalence rates of 
these conditions were 3 to 5 times as high as in the general population (Table 2.3).  
The prevalence rate of comorbidity increased progressively with age, and the age-specific 
rate increased from 24.1% in the 20–44 years group to around 70% among people aged  
65 years and over (Figure 2.4).   
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Note: People aged 20 years and over only are included. Due to the small sample size, people aged 20–44 years were grouped for analysis. 
Source: AIHW analysis of 2004–05 ABS National Health Survey Confidentialised Unit Record File.  
Figure 2.4: Comorbidity of CVD and diabetes among people with diabetes in the  
non-institutionalised adult population, by age group, 2004–05 
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Comorbidity of CVD and diabetes in the 
institutionalised population
The institutionalised adult population consists of people who can not continue to live at 
home due to disability or age-related frailty. Old people, especially those aged 85 years and 
over, are more likely to be institutionalised. In 2003, it was estimated that about 31% of those 
aged 85 years and over were institutionalised (ABS 2006a). Both CVD and diabetes are more 
common among older people. Therefore, the prevalence of CVD, diabetes and their 
comorbidity in the non-institutionalised population may understate the true prevalence in 
the whole population. This section focuses on reporting the prevalence of comorbidity of 
CVD and diabetes among the institutionalised adult population based on the 2003 ABS 
SDAC. The institutionalised adult population in this report refers to people aged 20 years or 
over and living in cared accommodation as residents. Cared accommodation comprises 
health establishments, such as hospitals, nursing homes, aged care hostels, hostels for people 
with disabilities and some cared parts of retirement villages. People living in cared 
accommodation are those who had been, or were expected to be, living there for three 
months or more (ABS 2005).  
According to this survey, an estimated 182,061 Australians aged 20 years and over were 
institutionalised in 2003. The majority were older people, with about 89.8% aged 65 years 
and over (Table A8).
Note: People aged 20 years and over only are included.  
Source: AIHW analysis of 2003 ABS Survey of Disability, Ageing and Carers Confidentialised Unit Record File. 
Figure 2.5: Prevalence of CVD and diabetes and their comorbidity in the institutionalised adult 
population, 2003 
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Around 101,954 (56.0%) people had CVD and 21,106 (11.6%) had diabetes in this population. 
About 14,722 (8.1%) of them were estimated to have both CVD and diabetes (Figure 2.5). The 
prevalence rate of comorbidity of these two conditions varied with age, increasing from 7.6% 
in the 20–74 years age group to 10.1% in the 75–84 years age group, and then decreasing to 
about 6.9% in those aged 85 years and over (Figure 2.6).  
Overall, men were more likely to have this type of comorbidity than women (8.6% versus 
7.8%, respectively). However, because of the small sample sizes, the differences between 
sexes can not be compared for each age group separately. Detailed data can be found in 
Table A4. 
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Note: People aged 20 years and over only are included. Due to the small sample size, people aged 20–74 years were grouped for analysis. 
Analysis can not be done by sex separately for the same reason. 
Source: AIHW analysis of 2003 ABS Survey of Disability, Ageing and Carers Confidentialised Unit Record File.  
Figure 2.6: Age-specific rate of comorbidity of CVD and diabetes in the institutionalised adult 
population, 2003 
Observed and expected comorbidity in the institutionalised adult 
population 
The prevalence rate of comorbidity of CVD and diabetes observed in the institutionalised 
adult population was 1.2 times as high as the rate that would be expected by chance  
(Table 2.4), but this difference is not statistically significant.  
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Table 2.4: Expected and observed comorbidity of CVD and diabetes in the institutionalised adult 
population, 2003 
Comorbidity 
Expected 
prevalence rate 
Observed 
prevalence rate 
Ratio observed to 
expected
(95% CI) 
CVD and diabetes           6.5% 8.1% 1.24 (0.73–1.75) 
CI Confidence interval 
Notes 
1. People aged 20 years and over only are included.  
2. Expected rate based on 56.0% with CVD and 11.6% with diabetes (56.0% × 11.6% = 6.5%). 
Source: AIHW analysis of 2003 ABS Survey of Disability, Ageing and Carers Confidentialised Unit Record File. 
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Comorbidity among people with CVD 
Among people with CVD in the institutionalised population, 14.4% also had diabetes  
(Table 2.5). Stroke was the form of CVD most likely to coexist with diabetes (16.6%). This 
was followed by heart disease (15.4%) and hypertension (15.0%). About 13.9% of those with 
other forms of CVD also had diabetes. The prevalence rate of comorbidity of CVD and 
diabetes also varied with age, decreasing from 20.6% in the 20–74 years group to around 
16.9% in the 75–84 years group, and then further declining to about 11.3% in the 85 years and 
over group (Figure 2.7).  
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Note: People aged 20 years and over only are included. Due to the small sample size, people aged 20–74 years were grouped for analysis. 
Source: AIHW analysis of 2003 ABS Survey of Disability, Ageing and Carers Confidentialised Unit Record File.  
Figure 2.7: Comorbidity of CVD and diabetes among people with CVD in the institutionalised 
adult population, by age group, 2003 
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Comorbidity among people with diabetes 
CVD was also common among people with diabetes in the institutionalised population. It 
was estimated that 69.8% of people who had diabetes also had at least one form of CVD. 
About 34.6% of these people had heart disease, 34.1% had stroke and 31.5% had 
hypertension. Around 8.6% of them also had other forms of CVD (Table 2.5).  
The prevalence rate of comorbidity of CVD and diabetes increased from 57.6% in the  
20–74 years group to around 76.4% among people aged 75–84 years, and then decreased to 
70.4% at ages 85 years and over among people with diabetes (Figure 2.8).  
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Note: People aged 20 years and over only are included. Due to the small sample size, people aged 20–74 years were grouped for analysis. 
Source: AIHW analysis of 2003 ABS Survey of Disability, Ageing and Carers Confidentialised Unit Record File.  
Figure 2.8: Comorbidity of CVD and diabetes among people with diabetes in the 
institutionalised adult population, by age group, 2003 
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3 Hospitalisations  
People with comorbidity have been found to use considerably more health resources, such as 
hospital services, GP visits and specialist consultations, than those without comorbidity 
(Westert et al. 2001). In this chapter, we examine the extent of comorbidity of CVD, diabetes 
and CKD in hospitalisations in 2004–05. We focus on presenting the number of hospital 
separations with any diagnosis (principal diagnosis and/or additional diagnoses) of two or 
three of the index conditions (CVD, diabetes and CKD), and the distribution of these hospital 
separations by age group and sex. Analysis was limited to separations for people aged 18 
years and over. 
The data presented in this chapter are drawn from the AIHW National Hospital Morbidity 
Database. This database includes data on virtually all hospital admissions in Australia, in 
both public and private hospitals. Data are collected for each episode of hospital care (called 
hospital separation), which starts when a patient is admitted to hospital and ends when the 
hospital stay ends, or there is a change in the type of care (for example, from acute care to 
rehabilitation hospital care). 
Most diseases or conditions (including CVD and CKD) are recorded as a diagnosis following 
these criteria:  
● diseases are recorded as principal diagnosis when they are considered to be the primary 
reason for the patient being hospitalised 
● diseases that coexist with the principal diagnosis, or arise during the episode of care, are 
recorded as additional diagnoses when they affect the management of patients in terms 
of requiring therapeutic treatment, diagnostic procedures, or increased nursing care 
and/or monitoring (NCCH 2002). 
In other words, a disease is not recorded as a diagnosis in hospital separations if it does not 
meet these criteria, even if patients had this disease when they were admitted to hospital. 
However, diabetes, along with a few other conditions, is treated as an exception—it is 
recorded as a diagnosis if people have this disease when they are hospitalised, regardless of 
the above criteria. As a consequence, the results of this analysis may underestimate the 
number of hospital separations with comorbidity of CVD, CKD or both.  
In addition, there may be some variations in coding practice between states and territories, 
particularly in the way comorbidity is recorded, which may also affect the results of the 
analyses in this report.  
It is also important to note that because hospital records are based on hospital separations, 
rather than individual patients, it is impossible to track patients between admissions. 
Therefore, the analyses presented here cannot identify whether different hospital separations 
relate to different patients or to a single patient with more than one episode of hospital care.  
In 2004–05, around 83% of adult hospitalisations with a diagnosis of CKD were attributed to 
regular dialysis in which ’Care involving dialysis’ was recorded as the principal diagnosis. 
Because the characteristics of these hospital separations are very different from others, and 
because of the large number of them, they have been analysed separately in this chapter.  
20
Hospitalisations with comorbidity of CVD, diabetes 
and CKD (excluding regular dialysis) 
There was a total of 5,573,327 hospital separations (excluding regular dialysis) among people 
aged 18 years and over in 2004–05. This type of hospitalisation is referred to as non-dialysis 
adult hospitalisation in the following section. The index condition with the largest number of 
separations was CVD (21.0% of all separations), followed by diabetes (8.3%) and CKD (2.9%) 
(Figure 3.1). In total, 24.6% of hospitalisations had at least one of the three conditions as a 
diagnosis.
Notes 
1. Hospital separations for regular dialysis were excluded from this analysis. 
2. Hospital separations for people aged 18 years and over only are included. 
Source: AIHW National Hospital Morbidity Database. 
Figure 3.1: Non-dialysis adult hospitalisations with diagnoses of CVD, diabetes, CKD and their 
comorbidity, 2004–05 
There were 365,243 separations with diagnoses of two or more index conditions, 
representing 6.6% of non-dialysis adult hospitalisations.  
The most common combination between index conditions was CVD and diabetes. There 
were 241,187 adult separations that recorded this type of comorbidity in 2004–05, accounting 
for 4.3% of all non-dialysis adult separations. This was followed by the combination of CVD 
and CKD (53,666 separations, 1.0%), and diabetes and CKD (9,975 separations, 0.2%). There 
were 60,415 (1.1%) separations with all three index conditions recorded (Table 3.1 and  
Table 3.3). 
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Table 3.1: Non-dialysis adult hospitalisations with comorbidity of CVD, diabetes and CKD, by  
sex and age group, 2004–05 
Comorbidity Men Women 
Odds ratio 
men to women
(95% CI)  
Under 
65 years 
65 years 
and over 
Odds ratio
65 years and over 
to under 65 years
(95% CIl) 
CVD and diabetes 
(without CKD)  
128,315 
(5.2%) 
112,872 
(3.6%) 
1.32
(1.31–1.33)  
76,377
(2.2%) 
164,810 
(8.0%) 
3.79
(3.76–3.82) 
CVD and CKD 
(without diabetes)  
30,349 
(1.2%) 
23,317 
(0.8%) 
1.43
(1.41–1.46)  
10,760
(0.3%) 
42,906 
(2.1%) 
6.66
(6.52–6.80) 
Diabetes and CKD 
(without CVD) 
5,509 
(0.2%) 
4,466 
(0.1%) 
1.46
(1.40–1.52)  
4,218
(0.1%) 
5,757 
(0.3%) 
2.24
(2.15–2.33) 
CVD and diabetes 
and CKD 
35,146 
(1.4%) 
25,269 
(0.8%) 
1.59
(1.56–1.61)  
17,791
(0.5%) 
42,624 
(2.1%) 
3.96
(3.89–4.03) 
All hospital 
separations 2,460,242 3,113,085 —  3,501,157 2,072,170 — 
CI Confidence interval 
Notes 
1. Hospital separations for regular dialysis were excluded from this analysis. 
2. Hospital separations for people aged 18 years and over only are included. 
Source: AIHW National Hospital Morbidity Database. 
Age and sex 
The overall proportion of hospital separations with comorbidities increased with age. After 
adjusting for sex, separations for older people (aged 65 years and over) were around 2 to 7 
times as likely to have two index conditions recorded and around 4 times as likely to have all 
three conditions recorded as separations for younger people (aged under 65 years) (Table 
3.1).  
After adjusting for age, separations for men were more likely to have these comorbidities 
recorded than those for women—men were 32–46% more likely to have two of the 
conditions recorded and 59% more likely to have all three conditions recorded (Table 3.1). 
Figure 3.2 illustrates the distribution of non-dialysis adult hospitalisations with each 
combination of comorbidity by age and sex. Detailed data can be found in Table A5. 
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Notes 
1. Hospital separations for regular dialysis were excluded from this analysis. 
2. Hospital separations for people aged 18 years and over only are included. 
3. Per cent in the figures is the percentage of total hospitalisations in corresponding age group. 
Source: AIHW National Hospital Morbidity Database. 
Figure 3.2: Age-specific rate of non-dialysis adult hospitalisations with comorbidity of CVD, 
diabetes and CKD, by sex, 2004–05 
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Observed and expected comorbidity in hospitalisations 
Combinations of these conditions may occur by chance in the same hospital separation. 
Table 3.2 lists the proportion of such combinations that would be expected by chance, along 
with the observed proportions in adult hospital separations in 2004–05. Combinations 
between two conditions only were observed around 3 to 5 times as often as expected by 
chance, while comorbidity of all three index conditions was observed around 22 times as 
often (Table 3.2). 
These findings were similar to the prevalence of comorbidity in the non-institutionalised and 
institutionalised populations. They suggest that coexistence of these diseases in 
hospitalisations is mainly attributed to the associations between the diseases. A large 
proportion of these hospitalisations could be reduced if the causes of such associations could 
be prevented. 
Table 3.2: Expected and observed non-dialysis adult hospitalisations with comorbidity of CVD, 
diabetes and CKD, 2004–05 
Comorbidities 
Expected
hospitalisation rate
 (per cent) 
Observed  
hospitalisation rate 
(per cent)  
Ratio observed to expected
(95% CI) 
CVD and diabetes (with and without CKD) 1.74 5.4 3.10 (3.09–3.11) 
CVD and CKD (with and without diabetes) 0.61 2.1 3.44 (2.42–3.46) 
Diabetes and CKD (with and without CVD) 0.24 1.3 5.41(5.38–5.46) 
CVD and diabetes and CKD  0.05 1.1 22.00 (21.83–22.17) 
CI Confidence interval 
Notes 
1. Hospital separations for regular dialysis were excluded from this analysis. 
2. Hospital separations for people aged 18 years and over only are included. 
3. Per cent in the table is the percentage of total hospital separations. 
4. See Appendix for an explanation of calculations of observed and expected hospitalisation rates. 
Source: AIHW National Hospital Morbidity Database. 
  24
Comorbidity in the context of each disease  
The proportion of hospital separations with comorbidity was different for each of the three 
conditions. The largest was CKD, with 75.8% of CKD separations also having a diagnosis of 
another index condition. This was followed by diabetes (67.5%) and CVD (30.4%) (Table 3.3). 
Table 3.3: Non-dialysis adult hospitalisations with index conditions and comorbidities, 2004–05 
Index condition 
Comorbidities 
Number of hospital 
separations  CVD Diabetes CKD 
Total hospital 
separations 
   Per cent 
CVD and diabetes (without CKD) 241,187  20.6 52.3 — 4.3 
CVD and CKD (without diabetes) 53,666  4.6 — 32.8 1.0 
Diabetes and CKD (without CVD) 9,975  — 2.2 6.1 0.2 
CVD and diabetes and CKD 60,415  5.2 13.1 36.9 1.1 
Proportion of hospital separations with 
index conditions that have comorbidities 
from other index conditions —  30.4 67.5 75.8 — 
Total hospital separations with 
comorbidity of index conditions 365,243  — — — 6.6 
Notes 
1. Hospital separations for regular dialysis were excluded from this analysis. 
2. Hospital separations for people aged 18 years and over only are included. 
3. Per cent in the table is the proportion of index condition hospitalisations with each comorbidity. Example: 52.3% of diabetes hospitalisations 
had comorbidity of CVD without CKD. 
Source: AIHW National Hospital Morbidity Database. 
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Comorbidity in hospitalisations with a diagnosis of CVD 
Of the hospital separations with a diagnosis of any form of CVD, more than 1 in 4 (25.8%) 
also had a diagnosis of diabetes. For some forms of CVD, the proportion of separations with 
diabetes was even higher than this average—hypertension (40.4%), heart failure (29.0%), 
CHD (25.1%), cerebrovascular disease (21.3%) and transient ischaemic attack (TIA) (16.7%). 
About 20.1% of hospital separations with other forms of CVD also recorded diabetes  
(Table 3.4). 
CKD was recorded as comorbidity in 9.7% of separations with CVD (Table 3.4). Heart failure 
occurred most frequently with CKD (23.5%), followed by hypertension (12.9%), CHD 
(11.2%), cerebrovascular disease (8.4%) and TIA (5.1%). About 11.3% of hospital separations 
with other forms of CVD also recorded CKD (Table 3.4). 
Hospitalisations with a diagnosis of CVD along with diabetes and/or CKD gradually 
increased from about 8% in the age group 18–24 to about 36% in the age group  
65–74, before decreasing slightly in the older age groups (Figure 3.3). 
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Figure 3.3: Comorbidity in non-dialysis adult hospitalisations with a diagnosis of CVD,  
by age group, 2004–05 
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Comorbidity in hospitalisations with a diagnosis of diabetes 
There were 461,416 non-dialysis adult hospital separations with a diagnosis of diabetes. 
About 65.4% of these separations also had a diagnosis of CVD. Nearly half (49.6%) had 
comorbidity of hypertension, followed by CHD (17.3%), heart failure (8.9%), cerebrovascular 
disease (4.9%) and TIA (0.6%). About 25.6% of these separations also recorded other forms of 
CVD (Table 3.4).  
Around 15.3% of the diabetes hospital separations recorded CKD as a comorbidity  
(Table 3.4). However, diabetes rarely coexists with CKD alone. Most separations with the 
comorbidity of diabetes and CKD also had at least one form of CVD (Table 3.3).  
Among hospital separations with a diagnosis of diabetes, the proportion of separations that 
also recorded CVD and/or CKD increased progressively with age, mainly due to an increase 
across age groups in the proportion with CVD (Figure 3.4).   
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Figure 3.4: Comorbidity in non-dialysis adult hospitalisations with a diagnosis of diabetes,  
by age group, 2004–05 
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Comorbidity in hospitalisations with a diagnosis of CKD 
Excluding hospital separations for regular dialysis, there were 163,588 hospital separations 
with a diagnosis of CKD in 2004–05. Nearly 70% of these separations also involved CVD, 
with hypertension (44.6%), CHD (21.8%) and heart failure (20.5%) commonly recorded. 
About 40.6% of these separations also recorded other forms of CVD (Table 3.4). 
Diabetes was recorded in around 43% of hospital separations with CKD, and most of them 
also had at least one diagnosis of CVD (Table 3.3 and 3.4).  
Among hospital separations with a diagnosis of CKD, the proportion of comorbidity with 
CVD and/or diabetes also increased progressively with age, mainly due to an increase 
across age groups in the proportion with CVD (Figure 3.5).   
Although CKD (excluding dialysis) accounted for a small proportion of hospital separations 
compared with CVD and diabetes, it had the greatest proportion of comorbidity across all 
age groups, and it also had the greatest proportion of comorbidity with both other index 
conditions (Figure 3.5).  
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Figure 3.5: Comorbidity in non-dialysis adult hospitalisations with a diagnosis of CKD, 
 by age group, 2004–05  
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Hospitalisations for regular dialysis  
There were 808,917 adult hospital separations in which ’Care involving dialysis’ was 
recorded as the principal diagnosis in 2004–05, representing 83.2% of adult hospital 
separations with a diagnosis of CKD and 12.7% of all adult hospital separations. As people 
with end-stage kidney disease go to hospital for day-stay admissions for regular dialysis  
3 times per week, these hospital separations represent a large number of hospital  
re-admissions for a relatively small population.  
Among these separations, 64,328 (8.0%) had an additional diagnosis of diabetes and 41,543 
(5.1%) had an additional diagnosis of CVD. The two forms of CVD most often recorded as an 
additional diagnosis were hypertension (4.4%) and CHD (0.1%). Around 1.4% of these 
separations also recorded other forms of CVD. Furthermore, 18,590 (2.3%) dialysis 
separations had both diabetes and CVD among their additional diagnoses  
(Table 3.5). 
There are differences between the proportion of comorbidities recorded in the AIHW 
National Hospital Morbidity Database and in other data sources. For example, about 5.1% of 
dialysis separations recorded CVD as an additional diagnosis, but the Australia and New 
Zealand Dialysis and Transplant Registry (ANZDATA) reported that about 28% of new 
patients had coronary artery disease in 2004 (McDonald et al. 2005).  
There are two possible reasons that may lead to this disparity. First, although a considerable 
proportion of people who were receiving dialysis had CVD, CVD might not affect regular 
dialysis, and therefore it is not recorded. Second, as the same patients attend the same 
dialysis unit or clinic a number of times, their medical records may be automatically 
repeated at each separation, rather than being re-recorded to reflect the comorbidities that 
they had, or were treated for, during each episode of hospital care.  
Table 3.5: Adult hospitalisations for regular dialysis, 2004–05 
Diagnosis Number Per cent 
Diabetes 64,328 8.0 
CVD 41,543 5.1 
Cerebrovascular disease 543 0.1 
CHD 927 0.1 
Heart failure 623 0.1 
Hypertension 35,279 4.4 
TIA 1 0.0 
Other CVD 11,663 1.4 
Comorbidity of CVD and diabetes  18,590 2.3 
Total adult hospitalisations for regular dialysis 808,917 100 
Note: Hospital separations for people aged 18 years and over only are included. 
Source: AIHW National Hospital Morbidity Database. 
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4 Deaths  
 
In this chapter, we examine the extent of comorbidity of CVD, diabetes and CKD in deaths 
registered in Australia in 2004. The data presented here are drawn from the AIHW National 
Mortality Database. These data are collected by the Registrars of Births, Deaths and 
Marriages in each state and territory and compiled nationally by the ABS, which codes the 
causes of death according to the International Classification of Diseases (ICD). 
Deaths registered in Australia may have more than one cause of death recorded on the death 
certificate. The disease or injury that initiated the train of events leading directly to death is 
defined as the ‘underlying cause of death’. In addition, any other condition or event that is 
not the underlying cause of death but is considered to have contributed to the death is 
known as an associated cause. This chapter focuses on those deaths where two or more of the 
index conditions were recorded among the underlying and associated causes listed on the 
death certificate.  
However, it is important to note that a condition is recorded as a cause of death only if it is 
judged to have contributed to the death. A disease will not be recorded in the death 
certificate if it does not meet this criterion even if people have this disease when they die. 
Therefore, results in this chapter represent the extent of comorbidity of the index condition as 
a cause of death (described here as ‘death with index conditions or comorbidity’), rather than 
the prevalence of these comorbidities among people who died.  
As with previous chapters, analysis here was limited to mortality records for people aged  
18 years and over.  
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Deaths with comorbidity of CVD, diabetes and CKD 
There were 130,521 deaths registered among people aged 18 years and over in Australia in 
2004. CVD, diabetes and CKD contributed largely to these deaths. CVD was recorded as a 
cause of death in 58.6%, while CKD and diabetes were each associated with about 9%  
(Figure 4.1). In total, 62% of deaths were associated with at least one of these conditions. 
At least two of CVD, diabetes and CKD were found in 17,239 death certificates, representing 
13.2% of all adult deaths. Comorbidity of CVD and diabetes contributed to 7,868 (6%), while 
comorbidity of CVD and CKD was associated with 7,116 (5.5%) deaths. Comorbidity of 
diabetes and CKD accounted for only 0.2% of adult deaths. About 1.5% of adult deaths had 
all three index conditions recorded. 
Note: Deaths for people aged 18 years and over only are included.
Source: AIHW National Mortality Database. 
Figure 4.1: Adult deaths with CVD, diabetes, CKD and their comorbidity, 2004 
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Age and sex 
The age-specific death rate increased with age for all combinations of these conditions. After 
adjusting for sex, the risk of having comorbidity was significantly greater among people 
aged 65 years and over than in younger people for all combinations of the index conditions, 
except for comorbidity of diabetes and CKD (Table 4.1).  
The overall proportion of deaths with comorbidity was greater for men than for women 
(Table 4.1). After adjusting for age, the differences between men and women were significant 
for comorbidity of CVD and diabetes, CVD and CKD and all three index conditions, but not 
significant for a combination of diabetes and CKD (Table 4.1). 
The distribution of comorbidity among age groups and sexes is presented separately for each 
combination in Figure 4.2. Detailed data can be found in Table A6. 
Table 4.1: Adult deaths with comorbidity of CVD, diabetes and CKD by sex and age group in 2004 
Comorbidity Men Women 
Odds ratio 
men to women
(95% CI)  
Under 
65 years 
65 years 
and over 
Odds ratio
65 years and over 
to under 65 years
(95% CI) 
CVD and diabetes  
(without CKD) 
4,163 
(6.2%) 
3,705 
(5.9%) 
1.12
(1.07–1.17)  
870
(3.5%) 
6,998 
(6.6%) 
2.02
(1.88–2.17) 
CVD and CKD 
(without diabetes)  
3,832 
(5.7%) 
3,284 
(5.2%) 
1.21
(1.15–1.27)  
427
(1.7%) 
6,689 
(6.4%) 
4.03
(3.65–4.46) 
Diabetes and CKD 
(without CVD) 
161 
(0.2%) 
155 
(0.2%) 
0.97
(0.77–1.21)  
67
(0.3%) 
249 
(0.2%) 
0.88
(0.67–1.16) 
CVD and diabetes 
and CKD 
1,081 
(1.6%) 
858 
(1.4%) 
1.24
(1.13–1.35)  
259
(1.0%) 
1,680 
(1.6%) 
1.61
(1.41–1.83) 
All deaths 67,238 63,283   —  25,121 105,400  — 
CI Confidence interval 
Note: Deaths for people aged 18 years and over only are included. 
Source: AIHW National Mortality Database. 
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Notes  
1. Deaths for people aged 18 years and over only are included. Due to the small numbers, some age groups were merged for analysis. 
2. Per cent in the figures is the percentage of total deaths in corresponding age group. 
Source: AIHW National Mortality Database 
Figure 4.2: Age-specific rate of deaths with comorbidity of CVD, diabetes and CKD, by sex, 2004 
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Observed and expected comorbidity among deaths  
Table 4.2 lists the proportion of such combinations that would be expected by chance alone, 
and the observed proportions among death records for adults in 2004. Combinations 
between CVD and diabetes, and CVD and CKD were observed 40% and 30% more often 
than would be expected by chance, respectively. The combination of diabetes and CKD was 
observed twice as often as expected and the combination of all three index conditions was 
observed 3 times as often (Table 4.2). 
The excess observed rate of comorbidity in deaths suggests that the coexistence of these 
diseases is caused by associations between these diseases. Thus, a considerable proportion of 
these deaths could potentially be prevented by reducing the factors that lead to such 
associations.  
Table 4.2: Expected and observed comorbidity among deaths for adults, 2004 
Comorbidity 
Expected death rate
(per cent) 
Observed death rate
(per cent) 
Ratio observed to expected
(95% CI) 
CVD and diabetes 
(with and without CKD) 5.3 7.5 1.42 (1.39–1.44) 
CVD and CKD 
(with and without diabetes) 5.4 6.9 1.28 (1.28–1.33) 
Diabetes and CKD 
(with and without CVD) 0.8 1.7 2.13 (2.04–2.22) 
CVD and diabetes and CKD  0.5 1.5 3.00 (2.87–3.14) 
CI Confidence interval 
Notes  
1. Deaths for people aged 18 years and over only are included. 
2. Per cent in the table is percentage of total deaths. 
Source: AIHW National Mortality Database. 
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Comorbidity in the context of each disease 
The proportion of deaths with comorbidity was different for each condition. About 86.3% of 
deaths with diabetes have another one or two diseases recorded. This was followed by CKD 
(78.7%) and CVD (22.1%) (Table 4.3). 
Table 4.3: Adult deaths with index conditions and comorbidities, 2004 
Index condition 
Comorbidity 
Number of 
deaths  CVD Diabetes CKD 
Proportion of 
total deaths 
   Per cent 
CVD and diabetes (without CKD) 7,868  10.3 67.1 — 6.0 
CVD and CKD (without diabetes) 7,116  9.3 — 59.7 5.5 
Diabetes and CKD (without CVD) 316  — 2.7 2.7 0.2 
CVD and diabetes and CKD 1,939  2.5 16.5 16.3 1.5 
Proportion of deaths with index conditions 
that have comorbidity of other index 
conditions —  22.1 86.3 78.7 — 
Total deaths with comorbidity of index 
conditions 17,239  — — — 13.2 
Notes 
1. Deaths for people aged 18 years and over only are included. 
2. Per cent in the table is the proportion of index condition deaths with each comorbidity. Example: 67.1% of diabetes deaths had comorbidity of 
CVD without CKD recorded. 
Source: AIHW National Mortality Database. 
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Comorbidity in deaths with CVD  
In 2004, 76,443 people had at least one form of CVD recorded on their death certificates, 
which represents 58.6% of all adult deaths in that year. About 22.1% of deaths with CVD also 
had at least one other index condition recorded. However, this proportion varied by age 
group, increasing from around 11.1% of adults aged 18–34 years to 26.1% for deaths at age 
65–74 years and then falling to 19.4% at age 85 years and over (Figure 4.3). 
Overall, of the deaths with CVD, about 12.8% also recorded diabetes. This proportion 
differed in different forms of CVD—hypertension (22.3%), CHD (15.0%), heart failure 
(13.4%), cerebrovascular disease (11.5%) and TIA (9.9%). About 12.9% of deaths with other 
forms of CVD also recorded diabetes (Table 4.4). 
About 11.9% of CVD deaths also recorded CKD. As with hospital separations, there was a 
strong association between heart failure and CKD in death records, where CKD contributed 
to more than 1 in 5 (21.3%) deaths with heart failure. In addition, 13.8% of hypertension 
deaths and 11.8% of CHD deaths also recorded CKD as a cause of death. CKD deaths were 
also associated with TIA (10.2%) and cerebrovascular disease (6.7%). About 13.0% of deaths 
with other forms of CVD also recorded CKD (Table 4.4). 
Around 2.5% of people who died with CVD had both diabetes and CKD recorded  
(Table 4.3). 
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Note: Deaths for people aged 18 years and over only are included. 
Source: AIHW National Mortality Database.  
Figure 4.3: Comorbidity among Australian adults with CVD as a cause of death, by age group, 
2004  
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Comorbidity in deaths with diabetes 
There were 11,732 deaths with diabetes in 2004, which represents 9.0% of all adult deaths.  
CVD contributed significantly to deaths with diabetes. About 83.6% of diabetes deaths had at 
least one form of CVD recorded. CHD was the most common (47.9%), followed by 
hypertension (28.6%) and heart failure (20.9%). In addition, more than 1 in 5 of them had 
cerebrovascular disease or TIA recorded (Table 4.4). About 36.4% of deaths with diabetes 
also recorded other forms of CVD. The strong association between CVD and deaths with 
diabetes appeared in all age groups. Around 47.6% of people aged 18–34 years had at least 
one form of CVD recorded if they died with diabetes. This proportion increased 
progressively with age to 86.9% at age 85 years and over (Figure 4.4).  
CKD was associated with 19.2% of deaths with diabetes (Table 4.4), and most of them also 
had CVD recorded (Table 4.3). 
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Note: Deaths for people aged 18 years and over only are included. 
Source: AIHW National Mortality Database.  
Figure 4.4: Comorbidity among Australian adults with diabetes as a cause of death, 
 by age group, 2004 
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Comorbidity in deaths with CKD 
There were 11,910 deaths where CKD was recorded as a cause of death, which represents 
9.1% of all adult deaths.  
About 76% of people who died with CKD also had at least one type of CVD recorded. CHD 
and heart failure were the most common forms of CVD—each of them contributed to more 
than a third of these deaths (36.9% and 32.6% respectively). In addition, 17.4% of these 
deaths were associated with hypertension and more than 12.4% of them were associated 
with cerebrovascular disease or TIA. About 36.3% of deaths with CKD also recorded other 
forms of CVD (Table 4.4). 
Diabetes was recorded as a cause of death in 18.9% of deaths with CKD, and most of them 
also had comorbidity of CVD (Tables 4.3 and 4.4). 
Among people who died with CKD recorded, the age-specific rate of comorbidity with the 
other two index conditions rose with age from 60.0% at age 18–34 years to 80.0% for deaths 
at age 85 years and over. The majority of these were deaths with both CKD and CVD  
(Figure 4.5). 
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Figure 4.5: Comorbidity among Australian adults with CKD as a cause of death, by age group,  
2004 
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5 Discussion 
The purpose of this report is to assess the extent of comorbidity of CVD, diabetes and CKD 
in Australia, and to provide background information for further investigations. We have 
investigated the extent of these comorbidities in the general population, in hospital 
separations and in death records. We have also examined differences in the distribution of 
these comorbidities among age groups, sexes and in the context of each individual disease.  
Extent of comorbidity  
• Overall, 417,563 (2.9%) Australian adults not living in institutions had both CVD and 
diabetes in 2004–05.  
• In 2003, 14,722 (8.1%) adults in institutions, such as nursing homes and aged care 
hostels, had both CVD and diabetes. 
• Comorbidities of two or more index conditions (CVD, diabetes and CKD) were found in 
365,245 (6.6%) non-dialysis hospital separations for adults in 2004–05.  
• Comorbidity of two or more index conditions (CVD, diabetes and CKD) were recorded 
as causes of death for 17,239 (13.2%) people who died in 2004.  
As discussed in the introduction to this report, there are a number of causes that can lead to 
this association. One of the major causes is shared common risk factors, such as poor 
nutrition, overweight and obesity, physical inactivity, smoking and high blood cholesterol. 
These risk factors do not just affect the onset of CVD, diabetes and CKD, but also accelerate 
their progression and increase the risk of complications. All these risk factors are common in 
the Australian population. Based on self-reported data, nearly 97% of adults had at least one 
of these risk factors in 2004–05: 54% were overweight or obese, 46% did not eat enough fruit, 
34% had very low levels of physical activity, 21% were daily smokers, and 9% had high 
blood cholesterol (AIHW 2006b). About 44% of Australian adults had multiple risk factors 
(AIHW 2006b). Moreover, it has been estimated that 19% of Australians aged 25 years and 
over have metabolic syndrome, and are at high risk of developing CVD, diabetes, CKD and 
their complications (Zimmet et al. 2005).  
For people with a single disease, adequate treatment and disease management are essential 
to prevent or delay the onset of its complications. This is especially important for preventing 
comorbidity of CVD, diabetes and CKD. However, there is substantial evidence that many 
people with these conditions do not achieve recommended treatment targets. Results from 
the 1999–2000 Australian Diabetes, Obesity and Lifestyle (AusDiab) study suggested that 
only half the participants met the individual blood sugar, lipid and blood pressure targets 
recommended at the time of the survey, and only about 1 in 7 met all three targets (Kemp et 
al. 2005). This survey also showed that over 53% of people with hypertension were untreated 
and only 19% had their blood pressure controlled (Briganti et al. 2003). The National 
Evaluation of the Frequency of Renal Impairment Co-existing with Non-insulin dependent 
diabetes mellitus (NEFRON) study showed that for more than 75% of patients with Type 2 
diabetes, their GP did not routinely monitor their kidney function (Thomas et al. 2006).  
In this report, we also found that the observed rate of these comorbidities greatly exceeded 
the expected rates if they happened by chance alone. The excess observed rate of 
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comorbidity occurred in the general population, as well as in hospitalisations and deaths. 
These results suggest that the coexistence of these diseases did not occur by chance and is 
mainly attributed to a strong association between the individual diseases. The causes of this 
association could be prevented by controlling common risk factors and by improving disease 
treatment and management. This could potentially reduce a great proportion of these 
comorbidities in the Australian population and a large number of hospitalisations and 
deaths associated with these comorbidities.  
In 2006, Australian governments agreed on the first National Chronic Disease Strategy 
(NCDS) to provide national policy directions for improving chronic disease prevention and 
care across Australia for the next 5 to 10 years. The NCDS indicates that health promotion 
and risk reduction interventions are not just for healthy people, but are also relevant across 
the disease continuum and benefit people who are at risk of chronic disease, or living with 
these diseases. The NCDS also emphasises that it is essential to provide integration and 
continuity of prevention and care to ensure that people receive all the services they need in a 
timely manner, thus maximising their health outcomes (NHPAC 2006). The findings in this 
report again highlight the importance of disease prevention and management that are 
identified by the NCDS.  
It is important to note that the extent of these comorbidities may vary between different 
population groups, such as those with disabilities, Indigenous people and people in different 
socio-economic groups. Examining these differences is very important to identify high-risk 
groups and to formulate effective and targeted health policies to reduce the disease burden. 
This is an area for future work.  
Comorbidity in different age groups, and its impact 
on health services and health policy 
The prevalence rate of comorbidity increased progressively with age before age 65 years, and 
then rose sharply in the 65 to 74 years age group. This rate remained high after age 75 years, 
although there was a slight decline. The decrease in prevalence rates in this age group is 
possibly due to the effect of ‘better survival’—most people with severe diseases are likely to 
die earlier, and therefore, people who survive to over 75 years (especially over 85 years) tend 
to be healthier.  
The overall pattern of distribution of comorbidity by age was consistent in the  
non-institutionalised population, the institutionalised population, hospitalisations and 
deaths. 
A continuing high prevalence rate of comorbidity among people aged 65 years and over 
would have a substantial impact on the Australian health system. The Australian population 
is ageing rapidly. According to the ABS, there were an estimated 2.4 million Australians 
aged 65 years and over at 30 June 2001 (ABS 2002). The ABS projected that the size of this 
group will increase to more than 4.2 million people by 2021 (ABS 2000). As the prevalence of 
CVD, diabetes and CKD, as well as many other chronic conditions, increases with age, this 
demographic trend leads to an increase in the size of the population with these diseases and 
at risk of comorbidity. Therefore, the number of people with comorbidity in the Australian 
population, as well as among those seeking health services, would increase quickly even if 
the prevalence rate of comorbidity does not rise above the current level in the future. 
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This increase will become a challenge to health services, health expenditure and policies. 
Studies have found that comorbidity is associated with greater use of health services, 
including more visits to GPs and specialists, longer consultation times, more hospital 
admissions and longer stay in hospital. In addition, people with comorbidities also have 
special health care needs. Unlike people with a single disease, disease management for 
people with multiple conditions needs to focus on several conditions at the same time. The 
interactions between multiple medications and therapies required for different diseases 
complicate treatment and may increase the risk of side effects. To meet such complex health 
care needs, health services not only need to increase in number, but require better 
coordination between health care professionals. 
Although the age-specific rates of comorbidity were much lower among younger people, the 
young made a big contribution to the burden of these comorbidities in terms of the absolute 
number of cases because people in younger groups comprise a large proportion of the 
population. About 43% of people with comorbidities in the non-institutionalised population, 
and 30–40% of those hospitalised, were aged less than 65 years. To reduce the burden of 
comorbidity effectively, disease prevention and detection interventions and policies need to 
start from a young age and take a whole-of-life approach.  
Differences between sexes 
Overall, the proportion of people with these comorbidities was greater among men than 
among women. In the younger age group, the prevalence of comorbidity was similar for 
both sexes, or only slightly higher for men. In the older age groups, prevalence rates among 
men were higher for all combinations of comorbidity studied. The higher proportion of 
comorbidity among men is in line with the greater prevalence of each individual disease in 
men. However, it is not clear if this is the full explanation.  
Comorbidity in the context of each individual 
disease 
Studies have demonstrated that CVD is a major cause of morbidity and mortality for people 
with diabetes and CKD (Garcia et al. 1974, AIHW 2005). The results in this report are 
consistent with this finding. We found that the prevalence of CVD among people with 
diabetes was 2.5 times as high as in the general population (60.6% versus 23.9%). The risk of 
having comorbidity with some forms of CVD was even greater—people with diabetes were  
3 to 5 times as likely to have hypertension, CHD, heart failure and cerebrovascular disease as 
the general population. We also found that over 65% of hospital separations with diabetes or 
CKD also involved CVD. CVD was recorded as a cause of death for over 75% of people who 
died with diabetes or CKD.  
These results suggest that CVD was very common among people with diabetes, and 
contributed largely to morbidity and mortality among people with diabetes and CKD. 
Diabetes and CKD lack specific symptoms in their early stages. For example, people with 
CKD may lose up to 85% of kidney function without manifestation. For this reason, the 
diagnosis of these diseases is often missed or delayed. In practice, some people with diabetes 
or CKD develop complications soon after these diseases are diagnosed. In some cases, they 
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already have complications when the diagnosis is made. Early detection is the key to 
preventing or delaying the development of CVD and other complications for these diseases.  
In addition, besides helping patients to achieve their recommended targets for individual 
diseases, health professionals should be vigilant for comorbidities from the early stage of 
these diseases, particularly in older patients. There is strong evidence that the risk of CVD 
can be reduced by appropriate management. For example, a large international study 
showed a 51% reduction in major cardiovascular events among people with diabetes when 
their blood pressure was controlled under 80 mmHg (Hansson et al. 1998).  
Compared with people with diabetes or CKD, the rate of comorbidities is relatively small 
among people with CVD. However, because a large number of people have CVD, 
comorbidity with diabetes and/or CKD account for many CVD cases. As both diabetes and 
CKD are major risk factors for CVD, there is the potential to prevent the occurrence of a 
number of CVD cases by reducing the number of cases of diabetes and CKD and their 
complications.  
Comparison of comorbidity estimates from various 
data sources 
The presence of comorbidity generally indicates more advanced disease and worse health. 
Thus, we would expect more people with these comorbidities among those in institutions 
such as hospitals and nursing homes, and among those who died, compared with the 
general community.  
This hypothesis is supported by comparisons of the crude rates of comorbidity between the 
data sources used in this report (Table 5.1). These showed that comorbidity was more 
common in the institutionalised population compared with the non-institutionalised 
population. Similarly, comorbidity was greater in the hospital data compared with the non-
institutionalised population and greater again in the mortality data. However, these 
differences were greatly reduced after the effect of differences in age structure was removed 
by age-standardising. The age-standardised rates indicate that the differences arising from 
the various data sources are related to differences in the age structure of the population 
represented in each data source. However, even with age-standardisation, there remains a 
pattern of greater comorbidity rates in hospitalisations compared with the non-
institutionalised population and greater comorbidity rates in the deaths data compared with 
hospitalisations. 
Although such comparisons provide some indication of comorbidity in the various settings, 
with implications for our understanding of these diseases, the comparisons should be treated 
with caution for several reasons. Firstly, the data in these sources were collected in different 
ways—the prevalence of comorbidity in the non-institutionalised and institutionalised 
populations was drawn from self-reported survey data, while hospital and mortality data 
were drawn from administrative data. Secondly, there is a slight difference in time frame of 
the data sources: SDAC—2003, NHS—2004–05, AIHW National Hospital Morbidity 
Database—2004–05 and AIHW National Mortality Database—2004. In addition, there are 
overlaps between the populations that were recorded in these data sources, especially 
between the hospitalised population and both the institutionalised and  
non-institutionalised populations.  
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Table 5.1: Comparison of comorbidity rates from various data sources  
   Prevalence(a)   
Comorbidity Sex   
 Non-
institutionalised  Institutionalised Hospitalisations(b) Deaths(c) 
   Crude rate (per cent) 
CVD and diabetes Men  1.50 8.60 6.60 7.80 
 Women  1.40 7.50 4.40 7.30 
CVD and CKD Men  n.a. n.a. 2.60 8.30 
 Women  n.a. n.a. 1.60 6.60 
Diabetes and CKD Men  n.a. n.a. 1.60 1.80 
 Women  n.a. n.a. 0.90 1.60 
CVD and diabetes and CKD Men  n.a. n.a. 1.40 1.60 
 Women  n.a. n.a. 0.80 1.40 
   Age-standardised rate (per cent) 
CVD and diabetes Men  3.07 n.a(d) 4.00 3.77 
 Women  2.69 n.a(d) 3.04 3.84 
CVD and CKD Men  n.a. n.a. 1.58 2.82 
 Women  n.a. n.a. 0.99 1.54 
Diabetes and CKD Men  n.a. n.a. 1.01 1.02 
 Women  n.a. n.a. 0.68 1.24 
CVD and diabetes and CKD Men  n.a. n.a. 0.85 0.82 
 Women  n.a. n.a. 0.56 0.98 
(a) Percentage of Australian population. 
(b) Percentage of total hospitalisations. 
(c) Percentage of total deaths. 
(d) Due to small sample size, the age-standardised rate in the institutionalised population can not be calculated by sex separately.  
n.a. not applicable 
Note: Rates were age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of 2004–05 ABS National Health Survey Confidentialised Unit Record File and 2003 ABS Survey of Disability, Ageing and 
Carers Confidentialised Unit Record File, AIHW National Hospital Morbidity Database and AIHW National Mortality Database. 
Data issues 
At present, there are no data explicitly collected routinely to monitor these comorbidities at 
the population level. The data presented in this report were drawn from the best national 
data sources available. However, because of some limitations of these sources, none of them 
can provide a complete picture for these comorbidities, and may lead to some 
underestimation of the true burden of these comorbidities. 
Both the NHS and the SDAC are very important information sources for chronic conditions. 
However, because both are self-reported surveys, the results are influenced by the 
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questionnaires used, and the knowledge and the awareness of specific conditions in the 
population. Self-reported data may underestimate the prevalence of diabetes especially, as 
some people with diabetes do not know they have the condition and therefore would not 
report it. Moreover, the prevalence of CKD is not available from either survey.  
The AIHW National Hospital Morbidity Database provides essential information regarding 
morbidity and hospital services in Australia. However, because records are based on 
hospitalisations (episodes of care) rather than individual patients, the database cannot 
identify whether records relate to different patients or to a single patient with more than one 
episode of care. In addition, CVD and CKD may not be recorded in hospital records if they 
are not thought to affect that episode of hospital care. As a consequence, the results of the 
analysis may underestimate hospitalisations with comorbidity involving these two diseases. 
There may also be a lack of consistency in coding practices between jurisdictions and over 
time, making the monitoring of these comorbidities more difficult.  
The AIHW National Mortality Database includes information on virtually all deaths. 
However, the data only represents the proportion of comorbidity as a cause of death, rather 
than the magnitude of comorbidity among people who have died. In addition, studies have 
shown that some diseases, such as CKD, were under-recorded in death certificates  
(Li et al. 2003).  
There is no integrated health database that can track patients across different health services 
and over time. It is impossible to know for how long the comorbidity has developed from 
the onset of a single disease, how patients with comorbidity are managed, and what are the 
outcomes of disease management. All these questions are critical to the monitoring and 
surveillance of comorbidity. 
As the burden of these comorbidities is expected to rise, the monitoring of these 
comorbidities is very important in terms of providing evidence for health policies and the 
appropriate level and combination of services to meet population needs. The gaps and 
limitations of the existing data sources suggest a need to improve information systems. 
Conclusion 
We found that CVD, diabetes and CKD coexisted in a considerable proportion of the 
Australian population. Comorbidity of these conditions especially affected older people, and 
men were at higher risk of these comorbidities than women. CVD was very common among 
people with diabetes, and contributed greatly to morbidity and mortality among people with 
diabetes and CKD. 
These comorbidities are largely attributed to shared risk factors and complex causal 
relationships between these diseases. There is a large potential to reduce the burden of these 
comorbidities by improving disease prevention and management. With our rapidly ageing 
population, Australian health systems need to be prepared to meet an increasing demand on 
health services from people with comorbidities, and to promote high quality and 
coordinated health care for these people.  
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Appendix 1: Statistical methods 
Age standardisation 
This is a method for removing the influence of age when comparing populations with 
different age structures. Age-standardised rates in this report were calculated using direct 
age-standardisation. The directly age-standardised rate is the weighted sum of age-specific 
(5-year age groups) rates, where the weighting factor is the corresponding age-specific 
standard population. For this report, the Australian estimated residential population as at  
30 June 2004 was used as the standard population. The same population was used for men 
and women to allow valid comparison of age-standardised rates between the sexes.  
Direct age standardisation 
Direct age standardisation is the most common method of age standardisation, and is used 
in this report for prevalence, hospitalisations and deaths data. This method of age-
standardisation is generally used when the population under study is large and the age-
specific rates can be reliably estimated. The calculation of direct age-standardised rates 
comprises three steps: 
Step 1: Calculate the age-specific rate for each age group. 
Step 2: Calculate the expected number of cases in each age group by multiplying the age-
specific rate by the corresponding standard population for each age group. 
Step 3: Sum the expected number of cases in each age group and divide this sum by the total 
of the standard population to give the age-standardised rate.  
Prevalence 
Prevalence refers to the number (of cases, instances, and so on) present in a population at a 
given time. 
Odds ratio and logistic regression 
Odds ratios in this report are calculated using logistic regression models. They are used in 
this report to estimate the difference in the distribution of comorbidities between age groups 
and between sexes after adjusting for interactions between sex and age. For example: the 
odds ratio of comorbidity of CVD and diabetes from men to women was 1.32, meaning that 
men were 1.32 times as likely as women to have comorbidity of CVD and diabetes if the 
male and female populations had the same age structure.  
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Expected rate, observed rate and ratio 
Any two diseases may occur in the same person by chance. The expected comorbidity rate is 
the rate that we would expect to see if the two diseases occurred together purely by chance. 
The observed comorbidity rate is the actual rate calculated from the number of cases of 
comorbidity that occurred in the population. The ratio of observed rate to expected rate is a 
measure of how much the observed rate differs from the expected rate. If the ratio is greater 
than one, then there are more cases of comorbidity than would be expected by chance (van 
den Akker M et al. 2001). In this report, the ratio of observed rate to expected rate is assessed 
using a 95% confidence interval. If the lower limit of the 95% confidence interval is greater 
than one, then the ratio is statistically significantly greater than one and we can conclude that 
the number of cases of comorbidity is greater than could be explained purely by chance.  
Expected rate: When two diseases occur together by chance, their expected comorbidity rate 
is the product of their individual rates.  
For example: 
Expected hospitalisation rate for comorbidity of CVD and diabetes (with and without CKD) 
 = hospitalisation rate of CVD (21.0%) × hospitalisation rate of diabetes (8.3%) × 100 = 1.74% 
Observed rate: This rate is calculated based on the actual number of cases of comorbidity 
that occurred in the population. 
For example: 
Observed number of hospitalisations with comorbidity of CVD and diabetes (with CKD)  
= 60,415 
Observed number of hospitalisations with comorbidity of CVD and diabetes (without CKD) 
= 241,187  
Observed number of hospitalisations with comorbidity of CVD and diabetes 
= 60,415 + 241,187 = 301,602 
Total hospitalisations = 5,473,337 
Observed hospitalisation rate with comorbidity of CVD and diabetes  
= 301,602/5,573,337 = 5.41%  
Ratio of observed rate to expected rate  
= observed rate (5.41%) / expected rate (1.74%) = 3.10  
95% confidence interval of the ratio of observed rate to expected rate for hospitalisation 
and mortality: 
If D is the observed number of events and E is the expected number of events, then  
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The expected rate is assumed to be constant, so the 95% confidence interval of the ratio of 
observed rate to expected rate will be 
⎥⎦
⎤⎢⎣
⎡
EE
UL μμ ,  
95% confidence interval of the ratio of observed rate to expected rate for 2004–05 NHS and 
2003 SDAC: 
The above formula is not applicable to estimates arising from a sample survey because it 
does not take account of the variability arising from the sampling process and the survey 
design. Instead the confidence interval is based on the survey standard errors as published 
by ABS (ABS 2006c). The ABS publishes a table of standard errors for selected values of 
estimates from the survey. The standard error of the estimated observed number (SE(a)) in 
the formula below is calculated by interpolating between adjacent values in the published 
standard error table. If D is the estimated observed number of events, DL and DU are 
adjacent numbers in the ABS standard error table, and lower SE(b) and upper SE(b) are their 
associated published standard errors, then 
SE(a) = lower SE(b) + ((
DLDU
DLD
−
− ) x (upper SE(b) – lower SE(b))) 
and 
SE(a)96.1SE(a)96.1 xDandxD UL +=−= μμ  
are the upper and lower limits of the 95% confidence interval around the observed number 
of events. If N is the total population and E is the estimated expected number of events, then 
the ratio of the observed to the expected rate is 
E
D
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ND =
/
/
 
The expected rate is assumed to be constant, so the 95% confidence interval of the ratio of 
observed rate to expected rate will be 
⎥⎦
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⎡
EE
UL μμ ,  
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Appendix 2: Classification of CVD, 
diabetes and CKD 
Cause of death and diagnosis of hospitalisation 
Australia uses the International Statistical Classification of Diseases and Related Health 
Problems, Tenth Revision (ICD-10) to code causes of death. The diagnoses associated with 
hospitalisations are coded according to the 10th revision of the International Classification of 
Diseases, Australian Modification (ICD-10-AM).  
For this report we used extended ICD–10 and ICD–10 AM codes to identify people with 
CVD, diabetes and CKD. Although some of these codes are not currently classified as 
diseases of the circulatory system, diabetes or diseases of the urinary system in ICD–10 or 
ICD–10 AM, the codes are recommended as appropriate and helpful to improve accuracy of 
identification of people with comorbidity by experts in the field. These codes are listed in 
Table A1. 
Comorbidity is identified if two or more index conditions were recorded as diagnoses in one 
hospital separation or as the cause of death in one death certificate. Conditions can be 
recorded as separate diagnoses or causes of death, or they can be recorded in one diagnosis 
or cause of death that contains two diseases, such as ‘diabetic renal complications’.  
Long-term conditions in the 2004–05 NHS and the 
2003 SDAC  
A long-term condition in the 2004-05 NHS is defined as ‘one reported by respondents as 
being a condition which they currently had and which had lasted or they expected to last for 
six months or more’. Some reported conditions were assumed to be long-term, including 
diabetes, rheumatic heart disease, heart attack and stroke. Long-term conditions in the  
2004–05 NHS were classified based on ICD-10 and were coded using the 2004–05 NHS 
confidentialised unit record file (CURF) codes (ABS 2006b). The CURF codes used to identify 
people with diabetes and CVD in the non-institutionalised population based on 2004–05 
NHS are listed in the Table A2.  
In the 2003 SDAC, a long-term condition is defined as ‘a disease or disorder which has lasted 
or is likely to last for at least six months; or a disease, disorder or event (such as stroke, 
poisoning, accident, and so on), which produces an impairment or restriction which has 
lasted or is likely to last for at least six months’. The long-term conditions in the 2003 SDAC 
were classified based on ICD-10 and were coded using the 2003 SDAC CURF codes (ABS 
2005). The CURF codes used to identify people with diabetes and CVD in the 
institutionalised population based on 2003 SDAC are listed in Table A3.  
Comorbidity is identified if a respondent reported they had both CVD and diabetes as long-
term conditions. 
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Appendix 3: Codes used in this report 
Table A1: Codes for deaths and hospital separations used in this report 
Disease ICD–10/ ICD–10 AM code Description 
CVD  
CHD I20–I25 Ischaemic heart disease 
Heart failure I50 Heart failure 
 I110 Hypertensive heart disease with (congestive) heart failure 
 I130 Hypertensive heart and renal disease with (congestive) heart 
 I132 Hypertensive heart and renal disease with (congestive) heart 
 I25.5 Ischaemic cardiomyopathy 
 I42.0 Dilated cardiomyopathy 
 I42.6 Alcoholic cardiomyopathy 
Cerebrovascular 
disease I60–I69 Cerebrovascular disease 
TIA G45 Transient cerebral ischaemic attacks and related syndromes 
 Hypertensive 
diseases I10 Essential (primary) hypertension 
 I119 Hypertensive heart disease without (congestive) heart failure 
 I12 Hypertensive renal disease 
 I131 Hypertensive heart and renal disease with renal failure 
 I139  Hypertensive heart and renal disease, unspecified 
Other CVD I00–I02 Acute rheumatic fever 
 I05–I09 Chronic rheumatic heart diseases 
 I26 –I28 Pulmonary heart disease and diseases of pulmonary 
 I30–I52 Other forms of heart disease 
 I70– I79 Diseases of arteries, arterioles and capillaries 
 
I80–I89 
Diseases of veins, lymphatic vessels and lymph nodes, not 
elsewhere classified 
 I95–I99 Other and unspecified disorders of the circulatory system 
 E10.5, E11.5, E13.5, E14.5 Diabetes with peripheral circulatory complications 
 E10.71, E11.71, E13.71, E14.71 Diabetes with multiple microvascular complications 
(continued) 
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Table A1 (continued): Codes for deaths and hospital separations used in this report  
Disease ICD-10/ICD-10 AM code Description 
Diabetes E10–E14 Diabetes mellitus 
CKD   
 B52.0(a) Plasmodium malariae malaria with nephropathy 
 D59.3(a) Haemolytic-uraemic syndrome 
 E10.2 Insulin-dependent diabetes mellitus with renal complication 
 E11.2 Non-insulin-dependent diabetes mellitus with renal complication 
 E12.2 Malnutrition-related diabetes mellitus with renal complication 
 E13.2 Other specified diabetes mellitus with renal complication 
 E14.2 Unspecified diabetes mellitus with renal complication 
 E85.1(a) Neuropathic heredofamilial amyloidosis 
 I12 Hypertensive renal disease 
 I13 Hypertensive heart and renal disease 
 I15.0 Renovascular hypertension
 I15.1 Hypertension secondary to other renal disorders 
 N00 Acute nephritic syndrome 
 N01 Rapidly progressive nephritic syndrome 
 N02 Recurrent and persistent haematuria 
 N03 Chronic nephritic syndrome 
 N04 Nephrotic syndrome 
 N05 Unspecified nephritic syndrome 
 N06 Isolated proteinuria with specified morphological lesion 
 N07 Hereditary nephropathy, not elsewhere classified 
 N08(b) Glomerular disorders in diseases classified elsewhere 
 N11 Chronic tubulo-interstitial nephritis 
 N12  Tubulo-interstitial nephritis, not specified as acute or chronic 
 N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular 
 N15 Other renal tubulo-interstitial diseases 
 N16(b) Renal tubulo-interstitial disorders in diseases classified 
 N18 Chronic renal failure 
 N19 Unspecified renal failure 
(continued) 
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Table A1 (continued): Codes for deaths and hospital separations used in this report  
Disease ICD-10/ICD-10 AM code Description 
 N25 Disorders resulting from impaired renal tubular function 
 N26 Unspecified contracted kidney 
 N27 Small kidney of unknown cause
 N28 Other disorders of kidney and ureter, not elsewhere classified 
 N39.1 Persistent proteinuria, unspecified 
 N39.2 Orthostatic proteinuria, unspecified 
 Q60  Renal agenesis and other reduction defects of kidney 
 Q61 Cystic kidney disease 
 Q62  Congenital obstructive defects of renal pelvis and congenital 
 Q63 Other congenital malformations of kidney 
 T82.4 Mechanical complication of vascular dialysis catheter 
 T86.1 Kidney transplant failure and rejection. 
 Z49(b)  Care involving dialysis
 Z94.0(b) Kidney transplant status 
 Z99.2(b)  Dialysis status 
(a) These codes are to be used for identification in mortality data only. 
(b) These codes are to be used for identification in hospital morbidity data only. 
Table A2: Codes used to identify CVD and diabetes in the non-institutionalised  
population, based on the 2004–05 NHS confidentialised unit record file (CURF) 
Disease CURF codes 
CVD  
CHD 19117, 19382 
Heart failure 19135 
Hypertensive diseases 19392 
Cerebrovascular disease 19396 
Other CVD 19114, 19403, 19402, 19067, 19116, 1937719389,19362 
Diabetes 14688, 14689, 14690 (a) 
(a) Gestational diabetes is not included. 
Source: ABS 2006b. 
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Table A3: Codes used to identify CVD and diabetes in the institutionalised  
population, based on 2003 SDAC confidentialised unit record file (CURF) 
Disease CURF codes 
CVD  
Heart disease 910, 913, 914, 919 
Hypertension 922 
Stroke 923 
Other CVD  929 
Diabetes 402 
Source: ABS 2005. 
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Appendix 4: Detailed statistical tables 
Table A4: People with comorbidity of CVD and diabetes in the non-institutionalised and 
institutionalised populations by age group and sex, aged 20 years and over, 2004–05 
Men  Women  Persons  
Age group Number Per cent  Number Per cent  Number Per cent 
Non-institutionalised population         
20–44 *9,612 0.3  *9,264 0.3  18,876 0.3 
45–54 29,940 2.2  24,057 1.7  53,997 2.0 
55–64 49,424 4.6  56,394 5.3  105,819 5.0 
65–74 75,319 11.4  62,702 9.0  138,021 10.2 
75–84 42,380 11.2  41,115 8.0  83,495 9.4 
85+ *6,474 7.8  *10,881 9.9  17,355 9.0 
Total 213,350 3.0  204,414 2.8  417,563 2.9 
Institutionalised population         
20–74 n.a. n.a.  n.a. n.a.  *2,719 7.6 
75–84 n.a. n.a.  n.a. n.a.  *5,961 10.1 
85+ n.a. n.a.  n.a. n.a.  *6,042 6.9 
Total *4,838 8.6  *9,884 7.8  14,722 8.1 
n.a.  not applicable 
* Estimate has a relative standard error of 25% to 50% and should be used with caution. 
Note: Due to small sample size, some age groups were merged for analysis. 
Source: AIHW analysis of 2004–05 ABS National Health Survey Confidentialised Unit Record File., AIHW analysis of 2003 ABS Survey of 
Disability, Ageing and Carers Confidentialised Unit Record File. 
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Table A5: Hospitalisations with comorbidity of CVD, diabetes and CKD, by age group and sex, for 
people aged 18 years and over, 2004–05 
Men  Women  Persons  
Age group Number Per cent  Number Per cent  Number Per cent 
Comorbidity of CVD and diabetes 
(without CKD)         
18–24 100 0.1  150 0.1  250 0.1 
25–34 667 0.3  729 0.1  1,396 0.2 
35–44 3,164 1.2  2,955 0.7  6,119 0.9 
45–54 11,913 3.4  9,007 2.2  20,920 2.7 
55–64 28,978 6.2  18,714 4.4  47,692 5.3 
65–74 39,738 8.4  30,731 7.5  70,469 8.0 
75–84 35,897 8.3  37,443 8.4  73,340 8.4 
85+ 7,858 6.6  13,143 6.9  21,001 6.8 
Total 128,315 5.2  112,872 3.6  241,187 4.3 
Comorbidity of CVD and CKD 
(without diabetes)         
18–24 150 0.1  183 0.1  333 0.1 
25–34 538 0.3  466 0.1  1,004 0.1 
35–44 1,034 0.4  737 0.2  1,771 0.3 
45–54 1,701 0.5  1,148 0.3  2,849 0.4 
55–64 2,858 0.6  1,945 0.5  4,803 0.5 
65–74 5,989 1.3  3,867 0.9  9,856 1.1 
75–84 11,780 2.7  7,958 1.8  19,738 2.3 
85+ 6,299 5.3  7,013 3.7  13,312 4.3 
Total 30,349 1.2  23,317 0.8  53,666 1.0 
(continued) 
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Table A5 (continued): Hospitalisations with comorbidity of CVD, diabetes and CKD, by age group 
and sex, for people aged 18 years and over, 2004–05  
Men  Women  Persons  
Age group Number Per cent  Number Per cent  Number Per cent 
Comorbidity of diabetes and CKD 
(without CVD)         
18–24 59 0.0  70 0.0  129 0.0 
25–34 117 0.1  302 0.1  419 0.1 
35–44 323 0.1  415 0.1  738 0.1 
45–54 655 0.2  580 0.1  1,235 0.2 
55–64 953 0.2  744 0.2  1,697 0.2 
65–74 1,378 0.3  934 0.2  2,312 0.3 
75–84 1,557 0.4  993 0.2  2,550 0.3 
85+ 467 0.4  428 0.2  895 0.3 
Total 5,509 0.2  4,466 0.1  9,975 0.2 
Comorbidity of CVD and diabetes and 
CKD         
18–24 150 0.1  183 0.1  333 0.1 
25–34 538 0.3  466 0.1  1,004 0.1 
35–44 1,034 0.4  737 0.2  1,771 0.3 
45–54 1,701 0.5  1,148 0.3  2,849 0.4 
55–64 2,858 0.6  1,945 0.5  4,803 0.5 
65–74 5,989 1.3  3,867 0.9  9,856 1.1 
75–84 11,780 2.7  7,958 1.8  19,738 2.3 
85+ 6,299 5.3  7,013 3.7  13,312 4.3 
Total 30,349 1.2  23,317 0.8  53,666 1.0 
Note: Per cent in the table is the percentage of hospitalisations in corresponding age group. 
Source: AIHW National Hospital Morbidity Database. 
 57 
Table A6: Deaths with comorbidity of CVD, diabetes and CKD for ages 18 years and over, by age 
group and sex, 2004 
Men  Women  Persons  
Age group Number Per cent  Number Per cent  Number Per cent 
Comorbidity of CVD and diabetes 
(without CKD)         
18–34 9 0.4  6 0.7  15 0.4 
35–44 29 1.4  24 2.0  53 1.6 
45–54 128 3.1  50 2.0  178 2.7 
55–64 411 5.5  213 4.8  624 5.2 
65–74 1,094 8.0  578 7.1  1,672 7.7 
75–84 1,659 7.2  1,469 7.4  3,128 7.3 
85+ 833 5.7  1,365 5.2  2,198 5.4 
Total 4,163 6.2  3,705 5.9  7,868 6.0 
Comorbidity of CVD and CKD 
(without diabetes)         
18–34 14 0.6  11 1.2  25 0.8 
35–44 34 1.6  17 1.4  51 1.5 
45–54 54 1.3  45 1.8  99 1.5 
55–64 167 2.2  85 1.9  252 2.1 
65–74 527 3.9  316 3.9  843 3.9 
75–84 1,636 7.1  1,122 5.6  2,758 6.4 
85+ 1,400 9.6  1,688 6.5  3,088 7.6 
Total 3,832 5.7  3,284 5.2  7,116 5.5 
(continued) 
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Table A6 (continued): Deaths with comorbidity of CVD, diabetes and CKD for ages 18 years and 
over, by age group and sex, 2004 
Men  Women  Persons  
Age group Number Per cent  Number Per cent  Number Per cent 
Comorbidity of diabetes and CKD 
(without CVD)         
18–54 15 0.2  13 0.3  28 0.2 
55–64 20 0.3  19 0.4  39 0.3 
65–74 37 0.3  25 0.3  62 0.3 
75–84 57 0.3  65 0.3  122 0.3 
85+ 32 0.2  33 0.1  65 0.2 
Total 161 0.2  155 0.2  316 0.2 
Comorbidity of CVD and diabetes 
and CKD         
18–44 13 0.3  13 0.6  26 0.4 
45–54 44 1.1  19 0.8  63 1.0 
55–64 92 1.2  78 1.8  170 1.4 
65–74 289 2.1  160 2.0  449 2.1 
75–84 456 2.0  363 1.8  819 1.9 
85+ 187 1.3  225 0.9  412 1.0 
Total 1,081 1.6  858 1.4  1,939 1.5 
Note: Per cent in the table is the percentage of deaths in corresponding age group. 
Source: AIHW National Hospital Mortality Database. 
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Table A7: People in the non-institutionalised population aged 20 years and over, by age  
group and sex, 2004–05 
Men  Women  Persons  
Age group Number Per cent  Number Per cent  Number Per cent 
20–24 698,723 9.8  666,134 9.1  1,364,857 9.5 
25–29 663,713 9.4  663,774 9.1  1,327,487 9.2 
30–34 732,752 10.3  753,407 10.3  1,486,159 10.3 
35–39 714,889 10.1  726,790 9.9  1,441,680 10.0 
40–44 753,376 10.6  764,177 10.4  1,517,553 10.5 
45–49 706,859 10.0  719,148 9.8  1,426,006 9.9 
50–54 644,431 9.1  664,388 9.1  1,308,819 9.1 
55–59 604,375 8.5  602,258 8.2  1,206,633 8.4 
60–64 460,043 6.5  453,548 6.2  913,592 6.3 
65–69 368,234 5.2  376,762 5.1  744,996 5.2 
70–74 291,162 4.1  317,511 4.3  608,673 4.2 
75–79 238,778 3.4  295,730 4.0  534,509 3.7 
80–84 139,377 2.0  219,449 3.0  358,826 2.5 
85+ 82,690 1.2  110,358 1.5  193,048 1.3 
Total 7,099,402 100.0  7,333,436 100.0  14,432,838 100.0 
Source: AIHW analysis of 2004–05 ABS National Health Survey Confidentialised Unit Record File. 
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Table A8: People in the institutionalised population aged 20 years and over, by age group  
and sex, 2003  
Men  Women  Persons  
Age group Number Per cent  Number Per cent  Number Per cent 
20–24 424 0.8  231 0.18  655 0.4 
25–29 699 1.3  514 0.41  1,213 0.7 
30–34 994 1.8  693 0.55  1,686 0.9 
35–39 1,107 2.0  642 0.51  1,749 1.0 
40–44 1,193 2.1  770 0.61  1,963 1.1 
45–49 1,612 2.9  990 0.79  2,602 1.4 
50–54 1,239 2.2  921 0.73  2,160 1.2 
55–59 1,433 2.6  1,235 0.98  2,668 1.5 
60–64 1,993 3.6  1,838 1.46  3,831 2.1 
65–69 3,093 5.5  3,329 2.64  6,423 3.5 
70–74 5,224 9.3  5,738 4.55  10,963 6.0 
75–79 7,949 14.2  14,013 11.12  21,963 12.1 
80–84 9,672 17.3  27,337 21.69  37,009 20.3 
85+ 19,393 34.6  67,785 53.78  87,178 47.9 
Total 56,024 100.0  126,037 100.0  182,061 100.0 
Source: AIHW analysis of 2003 ABS Survey of Disability, Ageing and Carers Confidentialised Unit Record File. 
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Table A9: Hospital separations for people aged 18 years and over, by age group and sex,  
2004–05 
Men  Women  Persons  
Age group Number Per cent  Number Per cent  Number Per cent 
18–19 37,960 1.5  61,613 2.0  99,573 1.8 
20–24 96,056 3.9  185,617 6.0  281,673 5.1 
25–29 93,507 3.8  230,777 7.4  324,284 5.8 
30–34 115,816 4.7  295,266 9.5  411,082 7.4 
35–39 124,526 5.1  240,533 7.7  365,059 6.6 
40–44 148,642 6.0  205,393 6.6  354,035 6.4 
45–49 162,127 6.6  202,285 6.5  364,412 6.5 
50–54 189,901 7.7  215,363 6.9  405,264 7.3 
55–59 237,361 9.7  225,526 7.2  462,887 8.3 
60–64 229,358 9.3  203,530 6.5  432,888 7.8 
65–69 235,780 9.6  203,473 6.5  439,253 7.9 
70–74 236,979 9.6  209,146 6.7  446,125 8.0 
75–79 244,468 9.9  235,680 7.6  480,148 8.6 
80–84 189,048 7.7  208,500 6.7  397,548 7.1 
85+ 118,713 4.8  190,383 6.1  309,096 5.5 
Total 2,460,242 100.0  3,113,085 100.0  5,573,327 100.0 
Source: AIHW National Hospital Morbidity Database. 
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Table A10: Deaths for ages 18 years and over, by age group and sex, 2004 
Men  Women  Persons  
Age group Number Per cent  Number Per cent  Number Per cent 
18–19 215 0.3  93 0.2  308 0.2 
20–24 592 0.9  223 0.4  815 0.6 
25–29 644 1.0  244 0.4  888 0.7 
30–34 876 1.3  322 0.5  1,198 0.9 
35–39 849 1.3  468 0.7  1,317 1.0 
40–44 1,287 1.9  725 1.2  2,012 1.5 
45–49 1,711 2.5  1,119 1.8  2,830 2.2 
50–54 2,376 3.5  1,413 2.2  3,789 2.9 
55–59 3,290 4.9  2,011 3.2  5,301 4.1 
60–64 4,235 6.3  2,428 3.8  6,663 5.1 
65–69 5,585 8.3  3,402 5.4  8,987 6.9 
70–74 8,036 12.0  4,799 7.6  12,835 9.8 
75–79 11,102 16.5  8,226 13.0  19,328 14.8 
80–84 11,809 17.6  11,763 18.6  23,572 18.1 
85+ 14,631 21.8  26,047 41.2  40,678 31.2 
Total 67,238 100.0  63,283 100.0  130,521 100.0 
Source: AIHW National Mortality Database. 
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Table A11: Australian population aged 20 years and over at 30 June 2001 
Men  Women  Persons  
Age group Number Per cent  Number Per cent  Number Per cent 
20–24 660,776 9.6  641,636 8.9  1,302,412 9.3 
25–29 700,910 10.2  706,171 9.8  1,407,081 10.0 
30–34 726,919 10.5  739,696 10.3  1,466,615 10.4 
35–39 741,434 10.8  750,770 10.5  1,492,204 10.6 
40–44 734,436 10.7  744,821 10.4  1,479,257 10.5 
45–49 675,055 9.8  683,539 9.5  1,358,594 9.7 
50–54 652,540 9.5  648,237 9.0  1,300,777 9.2 
55–59 512,888 7.4  495,911 6.9  1,008,799 7.2 
60–64 413,982 6.0  408,042 5.7  822,024 5.8 
65–69 335,590 4.9  346,923 4.8  682,513 4.8 
70–74 303,554 4.4  334,826 4.7  638,380 4.5 
75–79 227,356 3.3  292,000 4.1  519,356 3.7 
80–84 128,250 1.9  201,800 2.8  330,050 2.3 
85+ 81,922 1.2  183,313 2.6  265,235 1.9 
Total 6,895,612 100.0  7,177,685 100.0  14,073,297 100.0 
Note: This is the population used as the standard population in all age-standardised rates reported in this report.  
Source: ABS 2003; AIHW National Population Database. 
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